.png)
.png)
Latest news from BIA
CEO Update | 24 January 2022
I am looking forward to our first in-person events of 2022 this week, headlined by the BIA’s Annual Gala Dinner. This is a chance to celebrate the fantastic work undertaken by the sector throughout 2021 and raise money for our Charity Partner of the Year, Kidney Research UK. There are a few individual tickets left, so do book quickly if you are interested in attending.
What next for the COVID-19 taskforces?
Dr Ruth McKernan CBE, former chair of the BioIndustry Association and former Chair of Innovate UK, discusses the future of antivirals in relation to COVID-19 and how this works with current government processes.
CEO Update | 17 January 2022
The UK sector was out in virtual force at the annual JP Morgan Healthcare conference held virtually last week. It was great to see UK companies at the forefront of the global themes. I’m really looking forward to seeing many of you on 27 January as we gather in person to celebrate the achievements of the sector at the BIA Gala Dinner. I’m glad to confirm that Science Minister George Freeman MP will be our pre dinner keynote speaker.
Guest blog: Ochre Bio - Love Your Liver Month
Love Your Liver is a national awareness month devoted to liver health awareness and giving people the key steps needed to keep their liver healthy. We spoke to Ochre Bio, a liver medicines company, to find out what they're up to in this space.
BIA response to conclusion of NICE methods and processes review
The National Institute for Health and Care Excellence (NICE) has published its conclusions to its review of its methods and processes for Health Technology Assessments.
UK Life Sciences innovation highlighted by the Prime Minister at global healthcare investment conference
• Multiple UK deals and investments highlighted at key year opening global life science investment conference • Prime Minister Boris Johnson makes keynote address, highlighting strength of UK ecosystem to global investment community
A new era for the BIA as it announces new Chair and appointments to the Board plus key new hires
Following the BIA Annual General Meeting, the Association has announced its next Chair and members who have been elected to its Board of Directors. The AGM took place on Tuesday 19th October and the new board members were voted for by the BIA’s membership in the weeks leading up to the meeting
BIA reacts to £400m investment in the UK by Fujifilm Diosynth Biotechnologies
Reacting to news that Fujifilm Diosynth Biotechnologies will be investing £400m into their UK manufacturing operation Steve Bates OBE, Chief Executive of the Bioindustry Association said
Stablepharma is delighted to announce another new recruit to the Science Team in Spain
Stablepharma announce another new recruit to the Science team in Madrid, Spain based at Stablepharma’s R&D Center of Excellence (CoE) in Qube Technology Park
Medannex’s monoclonal antibody MDX-124 highly active in pancreatic cancer models
Data shows powerful synergy in combination with standard cancer treatments
Virology Research Services Chooses Discovery Park as it relocates London team
A team of virologists move to Discovery Park to expand operations. Demand for lab and manufacturing space continues at Discovery Park to support the UK’s booming life science industry.
BioIVT Launches GMP Grade Human AB Serum to Facilitate the Development and Manufacturing of Cell and Gene Therapies
This cell culture supplement can be used to manufacture both autologous and allogeneic cell therapies.
Here's a selection of featured BIA publications. See Resources Hub
Influencing and shaping our sector BIA update Q4 2021
The BioIndustry Association (BIA)’s ongoing engagement enables our members’ voices to be heard at the highest levels. This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from October 2021 to January 2022.
BIA submision to the S&T Select Committee inquiry on improving diversity in STEM
The BIA has responded to the Science & Technology Select Committee's consultation on diversity in STEM.
BIA submission to the UK IPO's consultation on AI and IP
The BIA has responded to the UK Intellectual Property Office’s consultation on copyright in works made by AI, text and data mining using copyright material, and patents for inventions devised by AI.
BIA response to consultation on proposals for change to NICE's methods, processes and topic selection
The BIA has responded to a consultation on proposals for change to NICE's methods, processes and topic selection.
